LOW-VOLUME · HOSP-MID
lisdexamfetamine Side Effects
lisdexamfetamine (also sold as Vyvanse) is a LOW-VOLUME FAERS extract #382 of 524 by FAERS report count. Still opens on HOSP-MID: 29.9% mention hospitalization (1,746 reports).
Data updated 2026-05-15
- 5,840
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
lisdexamfetamine: 29.9% mention hospitalization (1,746 reports). Death stamp DEATH-MARKED; volume band LOW-VOLUME #382 of 524 by FAERS report count.
Thinner FAERS extract for lisdexamfetamine (Vyvanse) (5,840 reports #382 of 524 by FAERS report count). 29.9% mention hospitalization (1,746 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2007–2025). Stamps WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
INTENTIONAL OVERDOSE leads 1,068 of 5,840 reports
Who reports · age peak 18-44 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 18-44 (1,589 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 208 reports (3.6% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| COMPLETED SUICIDE | 95 |
| TOXICITY TO VARIOUS AGENTS | 55 |
| CARDIO-RESPIRATORY ARREST | 38 |
| DEATH | 29 |
| CARDIAC ARREST | 23 |
| RESPIRATORY ARREST | 19 |
| HYPOTENSION | 13 |
| COMA | 12 |
| SUSPECTED SUICIDE | 12 |
| DEPRESSED LEVEL OF CONSCIOUSNESS | 10 |
| METABOLIC ACIDOSIS | 9 |
| RESPIRATORY DEPRESSION | 9 |
| ANION GAP | 7 |
| CIRCULATORY COLLAPSE | 6 |
| SEIZURE | 6 |
| ADRENERGIC SYNDROME | 5 |
| HYPERTHERMIA | 5 |
| AGGRESSION | 4 |
| AGITATION | 4 |
| BLOOD CREATINE PHOSPHOKINASE INCREASED | 4 |
Reactions in Hospitalization Reports
Hospitalization mid-share (1,746, 29.9%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| INTENTIONAL OVERDOSE | 895 |
| INTENTIONAL SELF-INJURY | 830 |
| DRUG INTERACTION | 105 |
| TOXICITY TO VARIOUS AGENTS | 95 |
| SUICIDE ATTEMPT | 77 |
| AGITATION | 59 |
| OVERDOSE | 54 |
| SEROTONIN SYNDROME | 48 |
| TACHYCARDIA | 47 |
| VOMITING | 46 |
| NAUSEA | 45 |
| HYPOTENSION | 43 |
| ANXIETY | 42 |
| CARDIOGENIC SHOCK | 41 |
| HEADACHE | 41 |
| HYPERHIDROSIS | 39 |
| SUICIDAL IDEATION | 37 |
| DEPRESSION | 33 |
How to read lisdexamfetamine FAERS figures (WATCHLIST · DEATH-MARKED · HOSP-MID)
FAERS holds 5,840 voluntary reports linked to lisdexamfetamine (Vyvanse), 2007-2025. Death is listed on 208 (3.6%). Hospitalization appears on 1,746 (29.9%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with lisdexamfetamine
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 5,825 FAERS cases (Δ 15 lighter vs lisdexamfetamine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 5,878 FAERS cases (Δ 38 heavier vs lisdexamfetamine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 5,880 FAERS cases (Δ 40 heavier vs lisdexamfetamine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 5,766 FAERS cases (Δ 74 lighter vs lisdexamfetamine); DEATH-MARKED · HOSP-LIGHT · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 58.5 pp vs lisdexamfetamine's DEATH-MARKED): CASELOAD · HOSP-MID.
lisdexamfetamine stamps WATCHLIST · SEX-BALANCED; class peers and methodology beat restating the same FAERS caveats on every effects URL.